US equities |
MU $877.55 ▲+2.46% NVDA $210.96 ▼-0.59% SPCX $147.49 ▲+1.89% AAPL $347.73 ▼-0.14% TSLA $372.22 ▼-0.63% SNDK $1,238.03 ▼-1.82% META $642.62 ▼-0.96% AMD $516.79 ▲+1.74%
FinancialContent

Latest News about Chikungunya

Recent news which mentions Chikungunya

Read Why Valneva's Stock Gained 7% Today
Tickers VALN
Tags Market News Biotech Briefs
From Benzinga
Valneva Kickstarts Phase 3 Trial Of Chikungunya Vaccine Candidate In Adolescents
Tickers VALN
Tags VALN Small Cap General
From Benzinga
Moderna Scraps mRNA-Based Antibody Program Targeting Chikungunya Virus
Tickers MRNA
Tags Movers MRNA General
From Benzinga
Valneva's Chikungunya Vaccine Candidate Shows Protective Neutralizing Antibodies In Late-Stage Trial
Tickers VALN
Tags Briefs Benzinga News
From Benzinga